한글목차

세계 위해의약품 조제 시스템 시장 전망은 병원내 약국, 외래/지역사회 약국, R&D 실험실 시장의 기회로 인해 유망합니다. 전 세계 위해의약품 조제 시스템 시장 규모는 2025-2031년 연평균 20.2%를 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 안전 규제 강화, 위해의약품 사용 증가, 의료 종사자의 안전 향상에 대한 관심입니다.

• Lucintel은 PCR 검사의 정확성과 신뢰성을 보장하기 위해 오염이 없는 진단 시약에 대한 수요가 증가함에 따라 유형별로는 무균 배합 시스템이 예측 기간 중 계속해서 큰 부문을 차지할 것으로 예상하고 있습니다.
• 용도별로는 병원 검사실에서 준비 시간을 단축하고, 안정적이고 바로 사용할 수 있는 시약에 대한 수요가 증가함에 따라 병원내 약국이 가장 큰 부문을 차지할 것으로 예측됩니다.
• 지역별로는 북미가 예측 기간 중 가장 높은 성장세를 보일 것으로 예측됩니다.

위해의약품 조제 시스템 시장의 새로운 동향

위해의약품 조제 시스템 시장은 안전성, 효율성, 규제 준수 향상과 관련된 몇 가지 새로운 동향을 통해 진화하고 있습니다.

• 위해의약품 조제 자동화: 위해의약품 조제 시장의 가장 두드러진 동향 중 하나는 자동화다. 로봇 조제 시스템이나 폐쇄형 시스템 약물 이송 장치와 같은 자동화 시스템은 인적 오류나 유해 의약품에 대한 노출을 최소화할 수 있으며, 채택이 증가하고 있습니다. 이러한 기술은 의료진이 위험한 화학물질에 노출되지 않도록, 특히 종양학 클리닉과 같은 고위험 환경에서 조제 과정의 정확성, 일관성, 안전성을 향상시켜 줍니다.
• 폐쇄형 약물전달 장치(CSTD)에 대한 수요 증가: 약물 오염 및 노출을 방지하는 고유한 툴로 작용하는 CSTD에 대한 수요가 증가하고 있습니다. CSTD는 이송 중 유해 의약품이 환경으로 유출되는 것을 방지하기 위해 고안된 시스템이며, FDA, OSHA 등 규제기관에서 그 사용을 중요시하고 있으며, 그 사용량은 앞으로도 계속 증가할 것으로 보입니다. 특히 CSTD는 화학요법제 및 기타 유해 의약품에 노출될 위험을 줄여 의료진과 환자 모두에게 안전한 결과를 초래하는 것을 목표로 하고 있습니다.
• 배합 기술 향상: 배합 기술 시스템의 발전으로 배합 시스템을 통한 약품 제조가 더욱 정확하고 효율적이며, 위해의약품 사용의 정확성과 안전성이 향상되고 있습니다. 기술 혁신은 교차 오염을 방지하고 약물의 정확한 투여를 위한 입구인 개선된 봉쇄 시스템을 통해 투여 정확도를 향상시키는 것으로 구성됩니다. 기술의 발전은 안전과 규제에 대한 높은 기준을 유지하기 위해 의료 기관이 새로운 모델의 조제 시스템을 지속적으로 업데이트하도록 유도하고 있습니다.
• 규제 변화 및 기준 준수: 전 세계 정부 및 규제기관은 유해 의약품 배합에 대한 규제를 강화하고 더 엄격한 기준을 시행하고 있습니다. 제약회사와 의료시설은 이러한 새로운 기준을 충족하는 장비에 투자하고 있습니다. 이러한 추세는 보다 안전하고 컴플라이언스를 준수하는 조제 시스템 시장을 주도하고 있습니다. 규제 준수에 대한 중요성이 강조되면서 의료진과 환자 모두를 위험 물질에 노출되지 않도록 보호하기 위해 위해의약품을 보다 안전하게 취급할 수 있게 되었습니다.
• 작업자 안전: 작업자 안전은 위해의약품 조제에서 가장 중요한 측면으로 남아있습니다. 의료 종사자 및 작업자의 유해 의약품에 대한 건강 피해에 대한 우려가 높아짐에 따라 작업자의 노출을 보호하는 시스템 개발에 더욱 힘을 쏟고 있습니다. 이러한 시스템은 아이솔레이터, 격리장치, 봉쇄장치, 개인보호구 등 약품과의 직접적인 접촉을 최소화하는 시스템입니다. 이러한 작업자 안전에 대한 관심 증가는 첨단 배합 시스템에 대한 수요를 증가시키는 강력한 요인이 될 것으로 보입니다.
• 세계 위해의약품 조제 시스템 시장 동향 : 폐쇄형 약물전달 장치, 기술 발전, 규제 준수, 작업자 안전, 자동화 동향은 세계 위해의약품 조제 시스템 시장을 변화시키고 있습니다. 이러한 추세는 계속 진화하고 있으며, 의약품 배합의 안전성, 효율성, 공정 준수에 대한 요구가 높아짐에 따라 시장의 발전이 기대됩니다.

최근 위해의약품 조제 시스템 시장의 발전

위해의약품 조제 시스템 시장에 영향을 미치는 주요 발전에는 안전성, 기술 및 규제 준수 개선이 포함됩니다.

• 자동 조제 시스템 : 의약품 조제의 정확성과 안전성을 높이기 위해 자동 조제 시스템이 도입되고 있습니다. 이러한 시스템은 인적 오류의 측면을 최소화하고, 효율성을 높이며, 위해의약품을 안전하게 취급할 수 있습니다. 헬스케어 분야의 자동화 수요 증가는 특히 종양 치료 센터와 같은 고위험 환경에서 이러한 시스템의 도입을 가속화하고 있습니다. 이러한 시스템은 프로세스를 최적화하는 동시에 의료 서비스 프로바이더가 엄격한 안전 기준을 준수할 수 있도록 돕습니다.
• 폐쇄형 약물 이송 장치: 폐쇄형 약물 이송 장치는 이송 중에 유해 의약품이 방출되지 않도록 설계되어 오염 및 노출의 위험을 피하고 보다 효과적인 약물 조제 작업을 보장합니다. 전 세계 규제기관이 조제 안전성을 촉진해야 한다고 주장하고 있으므로 의료시설은 서비스를 위해 폐쇄형 시스템을 구매하도록 요구하고 있습니다. 이러한 시설에서는 위해의약품 취급 및 화학요법 치료 서비스 영역이 표준이 되고 있습니다.
• 안전조치 개선을 위한 규제당국의 노력: 정부와 규제기관은 위해의약품의 조제 관련 안전조치를 강화하고 있습니다. FDA와 OSHA의 지침 개정 등 새로운 규제로 인해 의료시설은 보다 안전한 업무 수행을 위해 첨단 조제 시스템에 투자할 수밖에 없습니다. 이러한 규정은 의료 종사자의 위해의약품 노출 위험을 줄이고 약물이 정확하고 안전하게 조제될 수 있도록 보장합니다.
• 봉쇄 및 격리 기술 향상: 봉쇄 및 격리 기술의 향상으로 위해의약품 조제의 안전성이 향상되었습니다. 아이솔레이터와 생물학적 안전 캐비닛을 포함한 새로운 격리 시스템은 위해의약품에 대한 노출을 방지하기 위해 개발되었습니다. 이러한 기술은 약품 조제시 안전한 환경을 조성하여 의료 종사자 보호를 향상시킬 수 있습니다. 이러한 기술의 발전과 함께 전 세계 병원과 약국에서 도입이 확대될 것으로 예측됩니다.
• 교육 및 훈련의 중요성: 위해의약품에 대한 안전에 대한 우려는 지속적으로 증가하고 있으며, 이러한 의약품을 조제하는 의료진의 훈련과 교육도 중요한 과제로 대두되고 있습니다. 이러한 의료인들이 위험성 및 위해의약품 취급에 대한 충분한 지식을 습득할 수 있도록 교육 프로그램을 마련하고 있습니다. 또한 의료 종사자의 지식과 기술을 향상시키기 위해 위해의약품에 대한 교육 구상이 시장에 등장하고 있습니다.

자동화된 조제 시스템, CSTD, 규제에 대한 노력, 봉쇄 기술의 발전, 교육에 대한 높은 관심 등 이러한 발전은 모두 위해의약품 조제 시스템 시장을 보다 안전하고 효율적이며 컴플라이언스를 준수하는 시장으로 만들어 가고 있습니다. 이러한 개발 인프라가 속속 등장하면 위해의약품의 취급이 크게 개선되고, 의료 종사자의 안전이 보장될 것입니다.

목차

제1장 개요

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 거시경제 동향과 예측
• 업계 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 위해의약품 조제 시스템 시장 : 유형별

• 개요
• 유형별 매력 분석
• 멸균 조제 시스템 : 동향과 예측(2019-2031년)
• 비멸균 조제 시스템 : 동향과 예측(2019-2031년)

제5장 세계의 위해의약품 조제 시스템 시장 : 용도별

• 개요
• 용도별 매력 분석
• 원내 약국 : 동향과 예측(2019-2031년)
• 외래/커뮤니티 약국 : 동향과 예측(2019-2031년)
• 연구개발 실험실 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 세계의 위해의약품 조제 시스템 시장 : 지역별

제7장 북미의 위해의약품 조제 시스템 시장

• 개요
• 북미의 위해의약품 조제 시스템 시장(유형별)
• 북미의 위해의약품 조제 시스템 시장(용도별)
• 미국의 위해의약품 조제 시스템 시장
• 멕시코의 위해의약품 조제 시스템 시장
• 캐나다의 위해의약품 조제 시스템 시장

제8장 유럽의 위해의약품 조제 시스템 시장

• 개요
• 유럽의 위해의약품 조제 시스템 시장(유형별)
• 유럽의 위해의약품 조제 시스템 시장(용도별)
• 독일의 위해의약품 조제 시스템 시장
• 프랑스의 위해의약품 조제 시스템 시장
• 스페인의 위해의약품 조제 시스템 시장
• 이탈리아의 위해의약품 조제 시스템 시장
• 영국의 위해의약품 조제 시스템 시장

제9장 아시아태평양의 위해의약품 조제 시스템 시장

• 개요
• 아시아태평양의 위해의약품 조제 시스템 시장(유형별)
• 아시아태평양의 위해의약품 조제 시스템 시장(용도별)
• 일본의 위해의약품 조제 시스템 시장
• 인도의 위해의약품 조제 시스템 시장
• 중국의 위해의약품 조제 시스템 시장
• 한국의 위해의약품 조제 시스템 시장
• 인도네시아의 위해의약품 조제 시스템 시장

제10장 세계의 기타 지역의 위해의약품 조제 시스템 시장

• 개요
• 세계의 기타 지역의 위해의약품 조제 시스템 시장(유형별)
• 세계의 기타 지역의 위해의약품 조제 시스템 시장(용도별)
• 중동의 위해의약품 조제 시스템 시장
• 남미의 위해의약품 조제 시스템 시장
• 아프리카의 위해의약품 조제 시스템 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간 경쟁 관계
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 대체품의 위협
  • 신규 진출업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 유형별 성장 기회
  • 용도별 성장 기회
• 세계의 위해의약품 조제 시스템 시장에서의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증과 라이선싱
  • 합병, 인수, 계약, 제휴, 합병사업

제13장 밸류체인에서 주요 기업 개요

• 경쟁 분석
• BD Medical
• Equashield
• ICU Medical
• Simplivia
• B. Braun
• Baxter
• Comecer
• Grifols
• ARxiUM
• Newlcon

제14장 부록

• 그래프 리스트
• 표 리스트
• 조사 방법
• 면책사항
• 저작권
• 약어 및 기술 단위
• Lucintel 소개
• 문의

영문목차

The future of the global hazardous drug compounding system market looks promising with opportunities in the hospital pharmacies, outpatient/community pharmacies, and research and development laboratories markets. The global hazardous drug compounding system market is expected to grow with a CAGR of 20.2% from 2025 to 2031. The major drivers for this market are the increasing safety regulations, the rising use of hazardous drugs, and the focus on improving healthcare worker safety.

• Lucintel forecasts that, within the type category, sterile compounding systems will remain the larger segment over the forecast period due to rising demand for contamination-free diagnostic reagents to ensure accuracy and reliability in PCR testing.
• Within the application category, hospital pharmacies will remain the largest segment due to increasing demand for stable, ready-to-use reagents that reduce preparation time in hospital laboratories.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Hazardous Drug Compounding System Market

The hazardous drug compounding system market is evolving through several emerging trends that are concerned with the betterment of safety, efficiency, and regulatory compliance.

• Hazardous Drug Compounding Automation: One of the most prominent trends in the hazardous drug compounding market is automation. Automated systems, such as robotic compounding systems and closed-system drug transfer devices, are being adopted increasingly due to their potential to minimize human error and exposure to dangerous drugs. Such technologies improve the accuracy, consistency, and safety of the compounding process so that healthcare workers are not exposed to hazardous chemicals, especially in high-risk environments like oncology clinics.
• Emerging Demand for Closed System Transfer Devices (CSTDs): There is a rising demand for CSTDs that act as an inherent tool in preventing the contamination and exposure of drugs. CSTDs are a system designed to prevent hazardous drugs from escaping into the environment while transferring, and their usage will continue to grow as regulatory agencies such as the FDA and OSHA place emphasis on using them. Particularly, CSTDs are aimed at reducing risk in exposure to chemotherapy agents and other hazardous drugs, hence safety for both the healthcare workers and the patients.
• Improved Compounding Technology: Advances in technological systems in compounding are ensuring that more exact and efficient preparations of drugs by the compounding system enhance accuracy and safety in the use of hazardous drugs. Innovations in technology consist of better dosing accuracy with improved containment systems which are a gateway to the absence of cross-contamination and correct doses of drugs. Technological advances keep pushing healthcare institutions to update newer models of compounding systems for sustained high standards on safety and regulations.
• Regulatory Changes and Standards Compliance: Governments and regulatory agencies around the world are tightening regulations and enforcing stricter standards for hazardous drug compounding. Pharmaceutical companies and healthcare facilities are investing in equipment that meets these new standards. This trend is driving the market for safer, more compliant compounding systems. The increased focus on regulatory compliance ensures that hazardous drugs are handled more safely, with the goal of protecting both healthcare workers and patients from exposure to dangerous substances.
• Worker Safety: Worker safety continues to be the most essential aspect of hazardous drug compounding. Given increased concerns regarding the health hazards of hazardous drugs to healthcare personnel and workers, there is more effort put into developing systems that safeguard worker exposure. These systems are defined as isolators, containment devices, and personal protective equipment that minimize direct contact with these drugs. This growth in focus on worker safety will be a strong factor in the demand for advanced systems of compounding.
• Global Hazardous Drug Compounding System Market Trends: Closed-system transfer devices, advancements in technology, regulatory compliance, worker safety, and automation trends are transforming the global hazardous drug compounding system market. As these trends continue evolving, the market is expected to advance as well as develop, based on an increase in demand for safety, efficiency, and compliance with processes in drug compounding.

Recent Developments in the Hazardous Drug Compounding System Market

Some of the key developments influencing the hazardous drug compounding system market are safety, technology, and regulatory compliance improvements.

• Automated Compounding Systems: Automated compounding systems are being put in place to develop greater accuracy and safety for drug preparation. These systems minimize the human error aspects, efficiency, and safely working with hazardous drugs. The expanding demand for automation in healthcare is accelerating the uptake of these systems, especially in high-risk settings like oncology treatment centers. These systems are facilitating healthcare providers' observance of strict standards on safety while optimizing the process.
• Closed-system Drug Transfer Devices: Closed-system drug transfer devices, designed to avoid releasing hazardous drugs while the transfer is undergoing, ensure drug compounding operations are more effective in avoiding the risk of contamination and exposure. Since all regulatory agencies all over the globe are insisting that safety in compounding is promoted, healthcare institutions are demanding the purchase of closed systems for their services. In these facilities, it's becoming a standard with hazardous drugs' handling and a chemotherapy treatment service area.
• Regulatory Initiatives to Improve Safety Measures: Governments and regulatory agencies are tightening safety measures for hazardous drug compounding. New regulations, such as the revised guidelines of the FDA and OSHA, are compelling healthcare facilities to take safer practices and invest in advanced compounding systems. These regulations will reduce the risk of hazardous drug exposure for healthcare workers and ensure that drugs are compounded accurately and safely.
• Improvements in Containment and Isolation Technology: Improved containment and isolation technology have enhanced the safety of hazardous drug compounding. New containment systems, including isolators and biological safety cabinets, are being developed to prevent exposure to hazardous drugs. These technologies provide improved protection for healthcare workers by creating secure environments for drug compounding. As these technologies advance, they are expected to increase their adoption in hospitals and pharmacies around the world.
• Focus on Training and Education: The number of safety concerns about hazardous drugs is on the rise, and so is the training and education of healthcare workers in compounding these drugs. Training programs are being designed to ensure that these workers are well equipped with the dangers and handling of these hazardous drugs. Moreover, educational initiatives related to hazardous drugs have appeared on the market to enhance the knowledge and skills of healthcare professionals.

All these advancements about developing automated compounding systems, CSTDs, regulatory initiatives, advancement in containment technology, and high focus on training are making the hazardous drug compounding system market safer, more efficient, and compliant. As these development infrastructures continue to pop up, they would significantly improve the handling of hazardous drugs and safeguard the healthcare worker.

Strategic Growth Opportunities in the Hazardous Drug Compounding System Market

The global market for hazardous drug compounding systems comprises several growth prospects across key applications that include oncology drug compounding.

• Oncology Drug Compounding: The greatest growth opportunity in hazardous drug compounding systems is represented by oncology drug compounding. This fact is supported by the increasing incidence of cancer, coupled with the growing demand for chemotherapy drugs and treatment. Automated systems and CSTDs are particularly advantageous in oncology environments to prevent both contamination and exposure of toxic chemotherapy agents.
• Pharmacy Compounding Services: Pharmacy compounding services are the other area of growth, as healthcare providers seek customized medicines for patients. As regulations for compounding hazardous drugs are tightened, pharmacies opt for advanced systems that can meet the safety standards in preparation while assuring the exact drug preparation. The growth of personalized medicine and patient-specific formulations of drugs is going to keep up the demand for hazardous drug compounding systems in the pharmacies.
• Hospital and Clinic Adoption: Hazardous drug compounding systems are very important to hospitals and clinics that offer chemotherapy treatment. There is a growing interest in worker safety and regulatory compliance, which will cause healthcare facilities to adopt more advanced compounding technologies. These systems ensure accurate and safe drug preparation and are, therefore, essential in settings where patient safety and staff protection are the most important concerns.
• Veterinary Applications: Hazardous drug compounding systems have growing applications in veterinary medicine. As the use of hazardous drugs in veterinary oncology and other treatments increases, so does the need for systems that can compound and prepare them safely. Veterinary clinics and hospitals are incorporating automated compounding systems into their facilities to make the preparation of drugs safer and more efficient. Growth in this sector is becoming a result of adapting to such changes.
• Environmental and Safety Monitoring: The hazardous drug compounding market is witnessing an emerging growth opportunity in the form of environmental and safety monitoring. Importantly, monitoring systems assure the safe handling of hazardous drugs and track the resultant exposure levels; these are impacting significantly. Since healthcare facilities must comply with regulatory standards and maintain a safe environment for workers, there is much demand for comprehensive safety and environmental monitoring solutions.

These growth opportunities are based on oncology drug compounding, pharmacy services, hospital and clinic adoption, veterinary applications, and environmental monitoring, and will shape the future of the hazardous drug compounding system market. Demand for safer, more efficient systems will continue to drive market expansion based on these applications.

Hazardous Drug Compounding System Market Driver and Challenges

There are several drivers and challenges that are influencing the hazardous drug compounding system market, which includes technological, regulatory, and economic factors.

The factors responsible for driving the hazardous drug compounding system market include:

1. Advancements in Compounding Technology: Technological advancement is one of the major factors propelling the hazardous drug compounding system market. New automated systems, improved drug transfer devices, and containment technologies enhance the safety and efficiency of the drug compounding process. The innovation makes it easy for healthcare facilities to comply with the regulatory requirements and ensure the safety of healthcare workers and patients.

2. Focus on Worker Safety: With increased awareness regarding the risks of harmful drugs, there is a great need for safer compounding systems. There is an increasing emphasis on healthcare worker safety, which drives the adoption of technologies designed to minimize harmful exposures to hazardous substances. It is these increases in worker safety that are moving the markets toward greater advances in more protective compounding solutions.

3. Toughest Regulatory Standards: Stricter regulations by the FDA and OSHA for hazardous drug compounding are stimulating the growth in the hazardous drug compounding system market. In this regard, stringent regulations demand healthcare facilities to adopt safer methods of drug compounding, resulting in the rising demand for sophisticated systems that will meet these standards.

Challenges in the hazardous drug compounding system market are:

1. High Costs of Advanced Systems: The cost of advanced hazardous drug compounding systems is a significant challenge, especially for smaller healthcare facilities. These systems often require significant investments in equipment and training. High costs may deter the widespread adoption of these systems, especially in developing regions.

2. Regulatory Compliance Issues: While regulatory guidelines are pushing innovation, navigating the complex regulatory landscape for hazardous drug compounding systems is challenging. Constant updates to equipment and processes are necessary to keep pace with evolving safety standards, which can be time-consuming and costly for healthcare facilities.

3. Low awareness in emerging markets: The lack of awareness of drug compounding safety in hazardous situations in emerging markets is a key challenge to this market's growth. Most developing regions' hospitals and healthcare settings do not possess the necessary materials and knowledge base to implement leading-edge compounding systems. An awareness campaign concerning the need to compound drugs is essential for business expansion in those regions.

The hazardous drug compounding system market is driven by technological advancements, a focus on worker safety, and regulatory guidelines. Challenges such as high costs, regulatory compliance, and limited awareness in emerging markets are expected to impact the sustainability of market growth.

List of Hazardous Drug Compounding System Companies

• Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, hazardous drug compounding system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hazardous drug compounding system companies profiled in this report include:
• BD Medical
• Equashield
• ICU Medical
• Simplivia
• B. Braun
• Baxter
• Comecer
• Grifols
• ARxiUM
• Newlcon

Hazardous Drug Compounding System Market by Segment

The study includes a forecast for the global hazardous drug compounding system market by type, application, and region.

Hazardous Drug Compounding System Market by Type [Value from 2019 to 2031]:

• Sterile Compounding Systems
• Non-Sterile Compounding Systems

Hazardous Drug Compounding System Market by Application [Value from 2019 to 2031]:

• Hospital Pharmacies
• Outpatient/Community Pharmacies
• Research and Development Laboratories
• Others

Hazardous Drug Compounding System Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Hazardous Drug Compounding System Market

The global hazardous drug compounding system market has experienced rapid developments in the past few years, which are attributed to growing regulations and a safety focus in pharmaceutical compounding. Hazardous drug compounding is crucial in the preparation of drugs that are considered dangerous, such as chemotherapy agents. As awareness regarding the safe handling and preparation of these drugs increases, changes in regulations, technological advancements, and market demands are seen in countries such as the United States, China, Germany, India, and Japan. The market is responding with new innovations in compounding systems designed to protect healthcare workers and improve the overall efficiency of drug preparation.

• United States: This market, especially in the United States, is growing at an incredible pace due to stringent regulations by the FDA and OSHA. The push by the FDA for stiffer standards on compounding hazardous drugs, as enshrined in the Drug Quality and Security Act, among others, will influence the market. Investments in safer and more efficient compounding technologies are being made by pharmaceutical companies to adhere to these regulations. In addition, the need for automated compounding systems is growing, with healthcare facilities looking for ways to reduce human error and exposure to hazardous drugs, thus providing a safer workplace for staff.
• China: The Chinese hazardous drug compounding system market is rapidly growing, with the government strengthening its regulations on the safe handling of hazardous drugs. Growth in the Chinese pharmaceutical industry has also been stimulated through increasing demand for advanced drug compounding systems in oncology and chemotherapy treatments. Though the country has some difficulties with training workers and raising the public's awareness regarding safety standards, automation of compounding systems is the emerging trend. This change to automation will ensure that the drugs are prepared with greater efficiency and accuracy while at the same time reducing the dangers of handling hazardous drugs.
• Germany: Germany is moving its hazardous drug compounding system market forward with emphasis on safety for the workers and adherence to the regulatory requirements. The European Union's efforts to increase the strictness of guidelines on the handling of drugs have led Germany to use more advanced compounding technologies to adhere to the new standards of safety. The country has been embracing the use of closed-system drug transfer devices (CSTDs) and automated compounding devices in reducing the risks of drug contamination and exposure. The German market is expected to grow further because of the need for safety in drug compounding, especially in hospitals and oncology clinics.
• India: The hazardous drug compounding system market in India is increasing because of awareness about the risk associated with handling hazardous drugs. The pharmaceutical industry is expanding rapidly, and the number of cancer treatments is increasing. It is more crucial now than ever to have effective drug compounding systems. However, India lags behind in awareness and training in the right safety protocols. Still, there is a trend towards automation, which is reducing safety concerns and improving efficiency in drug compounding. According to the improvement and spreading awareness, India's hazardous drug compounding systems shall continue to market, which is gradually increasing.
• Japan: Japan's hazardous drug compounding system evolves with a clear focus on safety with its precision. Such a country seeks advanced compounding systems due to the increasing interest in oncological treatments and striving healthcare worker protection standards. This means that the country's healthcare sector has increasingly begun to adopt automated systems and technology for safer and efficient compounding. Additionally, there is an increase in the proportion of elderly citizens in the population that further leads to more patients seeking chemotherapy treatment. Japan is likely to continue on a straight growth path in the hazardous drug compounding system market as it continues improving the safety standards surrounding the handling of hazardous drugs.

Features of the Global Hazardous Drug Compounding System Market

• Market Size Estimates: Hazardous drug compounding system market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Hazardous drug compounding system market size by type, application, and region in terms of value ($B).
• Regional Analysis: Hazardous drug compounding system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hazardous drug compounding system market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hazardous drug compounding system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the hazardous drug compounding system market by type (sterile compounding systems and non-sterile compounding systems), application (hospital pharmacies, outpatient/community pharmacies, research and development laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Hazardous Drug Compounding System Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Sterile Compounding Systems: Trends and Forecast (2019-2031)
• 4.4 Non-Sterile Compounding Systems: Trends and Forecast (2019-2031)

5. Global Hazardous Drug Compounding System Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospital Pharmacies: Trends and Forecast (2019-2031)
• 5.4 Outpatient/Community Pharmacies: Trends and Forecast (2019-2031)
• 5.5 Research and Development Laboratories: Trends and Forecast (2019-2031)
• 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Hazardous Drug Compounding System Market by Region

7. North American Hazardous Drug Compounding System Market

• 7.1 Overview
• 7.2 North American Hazardous Drug Compounding System Market by Type
• 7.3 North American Hazardous Drug Compounding System Market by Application
• 7.4 United States Hazardous Drug Compounding System Market
• 7.5 Mexican Hazardous Drug Compounding System Market
• 7.6 Canadian Hazardous Drug Compounding System Market

8. European Hazardous Drug Compounding System Market

• 8.1 Overview
• 8.2 European Hazardous Drug Compounding System Market by Type
• 8.3 European Hazardous Drug Compounding System Market by Application
• 8.4 German Hazardous Drug Compounding System Market
• 8.5 French Hazardous Drug Compounding System Market
• 8.6 Spanish Hazardous Drug Compounding System Market
• 8.7 Italian Hazardous Drug Compounding System Market
• 8.8 United Kingdom Hazardous Drug Compounding System Market

9. APAC Hazardous Drug Compounding System Market

• 9.1 Overview
• 9.2 APAC Hazardous Drug Compounding System Market by Type
• 9.3 APAC Hazardous Drug Compounding System Market by Application
• 9.4 Japanese Hazardous Drug Compounding System Market
• 9.5 Indian Hazardous Drug Compounding System Market
• 9.6 Chinese Hazardous Drug Compounding System Market
• 9.7 South Korean Hazardous Drug Compounding System Market
• 9.8 Indonesian Hazardous Drug Compounding System Market

10. ROW Hazardous Drug Compounding System Market

• 10.1 Overview
• 10.2 ROW Hazardous Drug Compounding System Market by Type
• 10.3 ROW Hazardous Drug Compounding System Market by Application
• 10.4 Middle Eastern Hazardous Drug Compounding System Market
• 10.5 South American Hazardous Drug Compounding System Market
• 10.6 African Hazardous Drug Compounding System Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Hazardous Drug Compounding System Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 BD Medical
  • Company Overview
  • Hazardous Drug Compounding System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Equashield
  • Company Overview
  • Hazardous Drug Compounding System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 ICU Medical
  • Company Overview
  • Hazardous Drug Compounding System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Simplivia
  • Company Overview
  • Hazardous Drug Compounding System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 B. Braun
  • Company Overview
  • Hazardous Drug Compounding System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Baxter
  • Company Overview
  • Hazardous Drug Compounding System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Comecer
  • Company Overview
  • Hazardous Drug Compounding System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Grifols
  • Company Overview
  • Hazardous Drug Compounding System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 ARxiUM
  • Company Overview
  • Hazardous Drug Compounding System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Newlcon
  • Company Overview
  • Hazardous Drug Compounding System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us